Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCMSCs in mild to moderate Alzheimer's disease
NCT02672306Phase 2Unknown
- Sponsor
- South China Institute for Stem Cell Biology and Regenerative Medicine
- Start
- Oct 2017
- Primary completion
- Oct 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord derived mesenchymal stem cells in Alzheimer's disease (AD), sponsored by South China Institute for Stem Cell Biology and Regenerative Medicine. Status: unknown.
02
Drugs
human umbilical cord derived mesenchymal stem cells
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02672306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02672306.